ACUVUE? OASYS? PH

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a consumer,foreign report with the FDA on 2020-03-03 for ACUVUE? OASYS? PH manufactured by Johnson & Johnson Vision Care, Inc. ? Us.

Event Text Entries

[188140088] (b)(4). (b)(6).
Patient Sequence No: 1, Text Type: N, H10


[188140089] On (b)(6) 2019, a patient (pt) in (b)(6) reported headache, redness, pain, swelling, and pressure while wearing acuvue? Oasys? In the od on (b)(6) 2019. The pt? S od was red upon removal of the suspect cl. The pt did not seek medical attention. The pt reported using saline to clean and rinse cls. The pt reported a daily wear schedule with monthly replacement. No further information was provided. On (b)(6) 2019, a call was received from the pt stating that the od was still swollen, and the pt has not sought any medical attention. The pt reported wearing an old pair of cls previously reported. The pt? S od is currently red and swollen. No further information was provided. On (b)(6) 2020, the pt posted a complaint on an on-line website: the pt reported an allergy to the cls. The pt visited an ophthalmologist who advised the allergy was so severe that the pt is at risk of losing vision. The pt alleges 50% vision of the od. The pt is planning an appointment with a specialist for (b)(6) 2020. The pt noted feeling like? It is getting worse.? On 17feb2020, additional information was received from the pt: the pt did not have the treating eye care provider (ecp) contact information. The pt reported the ecp did not provide a diagnosis but referred the pt to a specialist. No treatment was prescribed. The pt has a specialist visit scheduled for (b)(6) 2020. No further information was provided. This event is being reported as a worst-case event as the diagnosis and treatment were unable to be verified with the treating ecp. A lot history review was performed and revealed the following: the batch record did not show any abnormalities in monomer and solution testing. All parameters tested were within specification. All sterilization requirements were successfully completed. Lot b00rhlm was produced under normal conditions. Two opened contact lens cases were received containing three contact lenses for lot # b00rhlm. The parameters of the three open lenses were measured, and a visual inspection was performed. The lenses met company standards for power, base curve, center thickness, and diameter. No visual attributes were observed for open contact lens # 1; open contact lens # 2 revealed an edge tear; open contact lens # 3 revealed a surface tear. If any further relevant information is received, a supplemental report will be filed.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1057985-2020-00021
MDR Report Key9779585
Report SourceCONSUMER,FOREIGN
Date Received2020-03-03
Date of Report2020-03-02
Date of Event2019-09-30
Date Mfgr Received2020-02-14
Date Added to Maude2020-03-03
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactROSE HARRELL
Manufacturer Street7500 CENTURION PARKWAY
Manufacturer CityJACKSONVILLE FL 32256
Manufacturer CountryUS
Manufacturer Postal32256
Manufacturer Phone9044433364
Single Use0
Previous Use Code0
Event Type3
Type of Report3

Device Sequence Number: 1

Brand NameACUVUE? OASYS?
Generic NameLENSES, SOFT CONTACT, EXTENDED WEAR
Product CodeLPM
Date Received2020-03-03
Returned To Mfg2020-01-23
Model NumberNA
Catalog NumberPH
Lot NumberB00RHLM
OperatorLAY USER/PATIENT
Device AvailabilityR
Device Sequence No1
Device Event Key0
ManufacturerJOHNSON & JOHNSON VISION CARE, INC. ? US
Manufacturer Address7500 CENTURION PARKWAY JACKSONVILLE FL US

Device Sequence Number: 101

Product Code---
Date Received2020-03-03
Device Sequence No101
Device Event Key0


Patients

Patient NumberTreatmentOutcomeDate
101. Other; 2. Required No Informationntervention 2020-03-03

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.